The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Open accessAbstract
In mostly small single-center studies, Alzheimer's disease (AD) is associated with characteristic and progressive reductions in fluorodeoxyglucose positron emission tomography (PET) measurements of the regional cerebral metabolic rate for glucose (CMRgl). The AD Neuroimaging Initiative (ADNI) is acquiring FDG PET, volumetric magnetic resonance imaging, and other biomarker measurements in a large longitudinal multi-center study of initially mildly affected probable AD (pAD) patients, amnestic mild cognitive impairment (aMCI) patients, who are at increased AD risk, and cognitively normal controls (NC), and we are responsible for analyzing the PET images using statistical parametric mapping (SPM). Here we compare baseline CMRgl measurements from 74 pAD patients and 142 aMCI patients to those from 82 NC, we correlate CMRgl with categorical and continuous measures of clinical disease severity, and we compare apolipoprotein E (APOE) varepsilon4 carriers to non-carriers in each of these subject groups. In comparison with NC, the pAD and aMCI groups each had significantly lower CMRgl bilaterally in posterior cingulate, precuneus, parietotemporal and frontal cortex. Similar reductions were observed when categories of disease severity or lower Mini-Mental State Exam (MMSE) scores were correlated with lower CMRgl. However, when analyses were restricted to the pAD patients, lower MMSE scores were significantly correlated with lower left frontal and temporal CMRgl. These findings from a large, multi-site study support previous single-site findings, supports the characteristic pattern of baseline CMRgl reductions in AD and aMCI patients, as well as preferential anterior CMRgl reductions after the onset of AD dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Peripheral resistance to insulin also occurs in the CNS, as the glucose metabolic rate is reduced in the brains of AD patients in fluorodeoxyglucose positron emission tomography (FDG PET) [118,119].”
From Neuroprotective effect of SGLT2 inhibitors. (2021) · cites this paper as [118]
In the citing paper
“Peripheral resistance to insulin also occurs in the CNS, as the glucose metabolic rate is reduced in the brains of AD patients in fluorodeoxyglucose positron emission tomography (FDG PET) [118,119].”
From Neuroprotective effect of SGLT2 inhibitors. (2021) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802
Self-citationReiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Self-citationMueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233
Self-citation(1995) · PubMed Central · doi:10.2967/jnumed.120.252510a · Cited by 996
Self-citationFunctional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977
Self-citationPositron Emission Tomography in Evaluation of Dementia
Silverman, D. H. S., Small, G. W., Chang, C. Y., Lu, C. S., de Aburto, M. A. K., Chen, W., Czernin, J. G., Rapoport, S. I., Pietrini, P., Alexander, G. E., et al. (2001) · JAMA · doi:10.1001/jama.286.17.2120 · Cited by 960
Self-citationBrain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease
Mosconi, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1762-7 · Cited by 938
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
Herholz, K., Salmon, E., Perani, D., Baron, J.-C., Holthoff, V., Frölich, L., Schönknecht, P., Ito, K., Mielke, R., & Kalbe, E. (2002) · NeuroImage · doi:10.1006/nimg.2002.1208 · Cited by 832
Mosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E. M., Holthoff, V., Kalbe, E., Sorbi, S., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045385 · Cited by 726
Self-citationde Leon, M. J., Convit, A., Wolf, O. T., Tarshish, C. Y., DeSanti, S., Rusinek, H., Tsui, W., Kandil, E., Scherer, A. J., Roche, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191044198 · Cited by 629
Small, G. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520360056039 · Cited by 604
Siebner, H. R., Riemenschneider, M. J., Willoch, F., Minoshima, S., Schwaiger, M., Kurz, A., Drzezga, A. E., & Lautenschlager, N. T. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1194-1 · Cited by 603
Positron emission tomography in Alzheimer's disease
Duara, R., Grady, C., Haxby, J. V., Sundaram, M., Cutler, N. R., Heston, L. L., Moore, A., Schlageter, N. L., Larson, S., & Рапопорт, С. И. (1986) · Neurology · doi:10.1212/wnl.36.7.879 · Cited by 568
Minoshima, S., Foster, N. L., Sima, A. A. F., Frey, K. A., Albin, R. L., & Kuhl, D. E. (2001) · Annals of Neurology · doi:10.1002/ana.1133 · Cited by 560
Self-citationHippocampal formation glucose metabolism and volume losses in MCI and AD
De Santi, S., de Leon, M. J., Rusinek, H., Convit, A., Tarshish, C. Y., Roche, A., Tsui, W. H., Kandil, E., Boppana, M., Daisley, K., et al. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00230-5 · Cited by 548
Foster, N. L., Chase, T. N., Fedio, P., Patronas, N. J., Brooks, R. A., & Chiro, G. D. (1983) · Neurology · doi:10.1212/wnl.33.8.961 · Cited by 540
Self-citationAlexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I., & Reiman, E. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.738 · Cited by 532
Self-citationImaging of amyloid burden and distribution in cerebral amyloid angiopathy
Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., Smith, E. E., Rosand, J., Rentz, D. M., Klunk, W. E., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21164 · Cited by 495
Reiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., & Frost, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061509598 · Cited by 467
Self-citationLimbic hypometabolism in Alzheimer's disease and mild cognitive impairment
Nestor, P. J., Fryer, T. D., Smielewski, P. S., & Hodges, J. R. (2003) · Annals of Neurology · doi:10.1002/ana.10669 · Cited by 429
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500579102 · Cited by 401
Self-citationCortical abnormalities in Alzheimer's disease
Foster, N. L., Chase, T. N., Mansi, L., Brooks, R., Fedio, P., Patronas, N. J., & Chiro, G. D. (1984) · Annals of Neurology · doi:10.1002/ana.410160605 · Cited by 378
Self-citationHippocampal hypometabolism predicts cognitive decline from normal aging
Mosconi, L., De Santi, S., Li, J., Tsui, W. H., Li, Y., Boppana, M., Laska, E., Rusinek, H., & de Leon, M. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.008 · Cited by 360
FDG PET imaging in patients with pathologically verified dementia.
Hoffman, J. M., Welsh-Bohmer, K. A., Hanson, M., Crain, B. J., Hulette, C. M., Earl, N., & Coleman, R. E. (2000) · PubMed · Cited by 350
Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease
Chételat, G., Desgranges, B., Landeau, B., Mézenge, F., Poline, J.-B., Sayette, V. D. L., Viader, F., Eustache, F., & Baron, J. (2007) · Brain · doi:10.1093/brain/awm288 · Cited by 349
MCI conversion to dementia and the APOE genotype
Mosconi, L., Perani, D., Sorbi, S., Herholz, K., Nacmias, B., Holthoff‐Detto, V., Salmon, É., Baron, J., Cristofaro, M. T. D., Padovani, A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000147469.18313.3b · Cited by 347
Reduced hippocampal metabolism in MCI and AD
Mosconi, L., Tsui, W. H., Santi, S. D., Li, J., Rusinek, H., Convit, A. J., Li, Y., Boppana, M., & de Leon, M. J. (2005) · Neurology · doi:10.1212/01.wnl.0000163856.13524.08 · Cited by 335
Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease
Ibáñez, V., Pietrini, P., Alexander, G. E., Furey, M. L., Teichberg, D., Rajapakse, J. C., Рапопорт, С. И., Schapiro, M. B., & Horwitz, B. (1998) · Neurology · doi:10.1212/wnl.50.6.1585 · Cited by 322
Self-citationAnchisi, D., Borroni, B., Franceschi, M., Kerrouche, N., Kalbe, E., Beuthien-Beumann, B., Cappa, S. F., Lenz, O., Lüdecke, S., Marcone, A., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.11.1728 · Cited by 320
Posterior cingulate cortex in Alzheimer's disease
MINOSHIMA, S. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92871-1 · Cited by 316 · cited 1×
“…et al., 1986; Foster et al., 1983, 1984; Haxby et al., 1990; Hoffman et al., 2000; Ibanez et al., 1998; Jagust et al., 1988; McGeer et al., 1990; Minoshima et al., 1994, 1995; Smith et al., 1992). multi-center (Herholz et al., 2002; Mosconi et al., 2008b; Silverman et al., 2001) FDG PET…”
Haxby, J. V., Grady, C. L., Koss, E., Horwitz, B., Heston, L. L., Schapiro, M. B., Friedland, R. P., & Rapoport, S. I. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530070043010 · Cited by 310
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
Jagust, W. J., Reed, B., Mungas, D., Ellis, W. G., & DeCarli, C. S. (2007) · Neurology · doi:10.1212/01.wnl.0000269790.05105.16 · Cited by 303
Self-citationArnáiz, E., Jelic, V., Almkvist, O., Wahlund, L.-O., Winblad, B., Valind, S., & Nordberg, A. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00045 · Cited by 302
Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
Drzezga, A. E., Grimmer, T., Riemenschneider, M., Lautenschlager, N. T., Siebner, H. R., Alexopoulus, P., Minoshima, S., Schwaiger, M., & Kurz, A. (2005) · PubMed · Cited by 277
de Leon, M. J., Ferris, S. H., GEORGE, A. E., Reisberg, ., Christman, D. R., Kricheff, I. I., & Wolf, A. P. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.57 · Cited by 197
Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography
Chase, T. N., Foster, N. L., Fedio, P., Brooks, R., Mansi, L., & Chiro, G. D. (1984) · Annals of Neurology · doi:10.1002/ana.410150732 · Cited by 179
Self-citationSmith, G. S. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530350056020 · Cited by 178
Chételat, G., Eustache, F., Viader, F., Sayette, V. D. L., Pèlerin, A., Mézenge, F., Hannequin, D., Dupuy, B., Baron, J., & Desgranges, B. (2005) · Neurocase · doi:10.1080/13554790490896938 · Cited by 164
Longitudinal studies of regional cerebral metabolism in Alzheimer's disease
Jagust, W. J., Friedland, R. P., Budinger, T. F., Koss, E., & Ober, B. A. (1988) · Neurology · doi:10.1212/wnl.38.6.909 · Cited by 154
Self-citationMielke, R., Herholz, K., Grond, M., Kessler, J., & Heiß, W.-D. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90015-p · Cited by 113
Regional cerebral glucose metabolism and postmortem pathology in Alzheimer’s disease
Mielke, R., Schröder, R., Fink, G. R., Kessler, J., Herholz, K., & Heiß, W.-D. (1996) · Acta Neuropathologica · doi:10.1007/s004010050410 · Cited by 107
Detection of isolated cerebrovascular β‐amyloid with pittsburgh compound B
Greenberg, S. M., Grabowski, T. J., Gurol, M. E., Skehan, M. E., Nandigam, R. N. K., Becker, J. A., Garcı́a-Alloza, M., Prada, C. M., Frosch, M. P., Rosand, J. M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21528 · Cited by 97
Comparability of FDG PET studies in probable Alzheimer's disease.
Herholz, K., Perani, D., Salmon, É., Franck, G., Fazio, F., Heiß, W.-D., & Comar, D. (1993) · PubMed · Cited by 77
McGeer, E. G., Peppard, R. P., McGeer, P. L., Tuokko, H., Crockett, D., Parks, R., Akiyama, H., Calne, D. B., Beattie, B. L., & Harrop, R. (1990) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029930 · Cited by 76
Mosconi, L., Tsui, W.-H., Pupi, A., Santi, S. D., Drzezga, A. E., Minoshima, S., & de Leon, M. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.040675 · Cited by 71
Choo, I. H., Lee, D. Y., Youn, J. C., Jhoo, J. H., Kim, K. W., Lee, D. S., Lee, J. S., & Woo, J. I. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3180687418 · Cited by 62
Frisoni, G. B., Henneman, W. J. P., Weiner, M. W., Scheltens, P., Vellas, B. J., Reynish, E. L., Hudecova, J., Hampel, H. J., Bürger, K., Blennow, K., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.04.009 · Cited by 51
Self-citationCerebral Metabolic Correlates of the Clinical Dementia Rating Scale in Mild Cognitive Impairment
Perneczky, R., Hartmann, J., Grimmer, T., Drzezga, A. E., & Kurz, A. (2007) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706297093 · Cited by 47
Bokde, A. L. W., Teipel, S. J., Drzezga, A. E., Thissen, J., Bartenstein, P., Dong, W., Leinsinger, G., Born, C., Schwaiger, M., Moeller, H. –., et al. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000088558 · Cited by 36
Kawano, M., Ichimiya, A., Ogomori, K., Kuwabara, Y., Sasaki, M., Yoshida, T., & Tashiro, N. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051253 · Cited by 25
Reiman, E. M., & Langbaum, J. B. S. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0020 · Cited by 16
Self-citationde Leon, M. J., SNIDER, D. A., & Federoff, H. J. (2007) · Cited by 9
Flagged first, then by citations
2 of the 59 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- De, 2001, Hippocampal formation glucose metabolism and volume losses in MCI and AD, Neurobiol. Aging, 22, 529, 10.1016/S0197-4580(01)00230-5 · DOI · Paper page
Cited by
Sorted by citations
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Reitz, C., & Mayeux, R. P. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.024 · Cited by 1,271
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1769 · Cited by 1,033
Self-citationBrain Imaging in Alzheimer Disease
Johnson, K. A., Fox, N. C., Sperling, R. A., & Klunk, W. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006213 · Cited by 875
Baker, L. D., Cross, D. J., Minoshima, S., Belongia, D., Watson, G. S., & Craft, S. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.225 · Cited by 639
Functional connectivity density mapping
Tomasi, D. G., & Volkow, N. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001414107 · Cited by 645
Metadata
- Authors
- Langbaum, J. B. S., Chen, K., Lee, W., Reschke, C., Bandy, D., Fleisher, A. S., Alexander, G. E., Foster, N. L., Weiner, M. W., Koeppe, R. A., Jagust, W. J., & Reiman, E. M.
- Affiliations
- Banner Alzheimer’s Institute (US)
- University of Arizona (US)
- University of California San Diego (US)
- University of Utah (US)
- San Francisco VA Medical Center (US)
- University of Michigan (US)
- University of California, Berkeley (US)
- Translational Genomics Research Institute (US)
- Corresponding author
- Reiman, Eric M.
- ORCID
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 45
- Issue
- 4
- Pages
- 1107-1116
- ISSN
- 1053-8119 (ISSN-L)
- PMC
- PMC2886795
- OpenAlex
- W2016228161
- Cited by
- 279
- References
- 59
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 10 · 2023: 6 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 26 · 2017: 14 · 2016: 21 · 2015: 15 · 2014: 22 · 2013: 26 · 2012: 24
- FWCI
- 18.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- NeuroImage (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u01ag024904-10)
- National Institute on Aging (U01-AG-024904, P30AG019610, U19AG010483)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- Alzheimer's disease, amnestic mild cognitive impairment, FDG-PET, regional cerebral glucose metabolism, posterior cingulate cortex, precuneus, frontal and temporal cortex, disease severity, Mini-Mental State Examination, APOE ε4, ADNI
- MeSH terms
- Aged, Alzheimer Disease, Cerebral Cortex, Cognition Disorders, Female, Humans, Male, Middle Aged, Reference Values, Sensitivity and Specificity, Statistics as Topic, Reproducibility of Results, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
